Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BJDX Bluejay Diagnostics Inc

Market Closed 06-26 16:00:00 EDT

2.93

-0.38

-11.48%

盘后2.98

+0.05+1.71%

19:05 EDT

High3.37	Low2.73	Vol56.54K
Open3.23	D1 Closing3.31	Amplitude19.18%
Mkt Cap3.03M	Tradable Cap2.47M	Total Shares1.03M
T/O173.29K	T/O Rate6.70%	Tradable Shares844.20K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BJDX","market":"US","secType":"STK","nameCN":"Bluejay Diagnostics Inc","latestPrice":2.93,"timestamp":1782504000000,"preClose":3.31,"halted":0,"volume":56541,"hourTrading":{"tag":"盘后","latestPrice":2.98,"preClose":2.93,"latestTime":"19:05 EDT","volume":326,"amount":950.2737,"timestamp":1782515150677,"change":0.05,"changeRate":0.017065,"amplitude":0.017065},"delay":0,"changeRate":-0.11480362537764346,"floatShares":844200,"shares":1034700,"eps":-10.451866,"marketStatus":"Market Closed","change":-0.38,"latestTime":"06-26 16:00:00 EDT","open":3.23,"high":3.365,"low":2.73,"amount":173288.326866,"amplitude":0.191843,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-10.451866,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782720000000},"marketStatusCode":7,"adr":0,"listingDate":1636520400000,"exchange":"NASDAQ","adjPreClose":3.31,"preHourTrading":{"tag":"盘前","latestPrice":3.4697,"preClose":3.31,"latestTime":"09:28 EDT","volume":1505,"amount":4692.368765,"timestamp":1782480506193,"change":0.1597,"changeRate":0.048248,"amplitude":0.144924},"postHourTrading":{"tag":"盘后","latestPrice":2.98,"preClose":2.93,"latestTime":"19:05 EDT","volume":326,"amount":950.2737,"timestamp":1782515150677,"change":0.05,"changeRate":0.017065,"amplitude":0.017065},"volumeRatio":0.5929903305187028},"requestUrl":"/m/hq/s/BJDX","defaultTab":"news","newsList":[{"id":"2644225397","title":"Bluejay Diagnostics files to sell 11.22M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2644225397","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644225397?lang=en_us&edition=fundamental","pubTime":"2026-06-18 05:25","pubTimestamp":1781731509,"startTime":"0","endTime":"0","summary":"17:21 EDT Bluejay Diagnostics (BJDX) files to sell 11.22M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-files-to-sell-11-22m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-files-to-sell-11-22m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642413551","title":"Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2642413551","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642413551?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:47","pubTimestamp":1781045237,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) has issued an update. At its June 9, 2026 annual meeting, Bluejay Diagnostics shareholders re-elected all incumbent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-shareholders-approve-stock-plan-and-flexibility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-shareholders-approve-stock-plan-and-flexibility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642490056","title":"Bluejay Diagnostics shareholders approve 600,000-share increase to 2021 stock plan reserve","url":"https://stock-news.laohu8.com/highlight/detail?id=2642490056","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642490056?lang=en_us&edition=fundamental","pubTime":"2026-06-10 05:27","pubTimestamp":1781040423,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics held its annual shareholder meeting on June 9, 2026.Shareholders backed an amendment allowing a reverse stock split within a 1-for-2 to 1-for-20 range; no split has been implemented.Investors adopted an amendment to the 2021 stock plan, lifting the share reserve by 600,000 to 600,061 shares.Shareholders ratified Wolf & Company as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL145Yz7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642843718","title":"Bluejay Diagnostics Completes Private Placement to Extend Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2642843718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642843718?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:52","pubTimestamp":1780959169,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On June 2, 2026, Bluejay Diagnostics entered into securities purchase and regi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-private-placement-to-extend-runway?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-private-placement-to-extend-runway?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642434728","title":"Bluejay Diagnostics prices USD 8.5 million at-the-market private placement of shares, warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2642434728","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642434728?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:16","pubTimestamp":1780953363,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics priced an at-the-market private placement targeting USD 8.5 million gross proceeds, with up to USD 15.1 million from warrant exercises.Offering covers 3,655,917 common shares or pre-funded warrants, with Series G warrants and short-term Series H warrants for the same share count.Purchase price set at USD 2.33 per share or pre-funded warrant; Series G and Series H warrants carry a USD 2.08 exercise price.Net proceeds expected to extend cash runway into Q1 2027; full cash warrant exercise could extend runway beyond FDA approval and first commercialization year.Closing expected around June 3, 2026; proceeds earmarked for FDA approval work, related clinical studies, R&D, working capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL1qvFFl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641123238","title":"Bluejay Diagnostics Announces Closing of up to $23.7 Million Private Placement Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2641123238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641123238?lang=en_us&edition=fundamental","pubTime":"2026-06-06 08:13","pubTimestamp":1780704804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260606:nTUA4BNFXH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641123233","title":"Press Release: Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2641123233","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641123233?lang=en_us&edition=fundamental","pubTime":"2026-06-06 08:13","pubTimestamp":1780704780,"startTime":"0","endTime":"0","summary":"$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants. Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash, it is anticipated that the cash runway would extend well beyond FDA approval and first full year of commercialization. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.The securities described above were offered in a private placement under Section 4 of the Securities Act of 1933, as amended , and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the securities issued in the private placement and shares of common stock underlying the warrants may not be offered or sold in the United States except pursuant to an effecti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NQmain","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640423079","title":"Bluejay Diagnostics prices USD 8.5 million at-the-market private placement of shares, warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2640423079","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640423079?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:19","pubTimestamp":1780417159,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics priced an at-the-market private placement for 3,655,917 common shares or pre-funded warrants at USD 2.33 each.Deal includes Series G warrants, short-term Series H warrants for up to 3,655,917 shares each; exercise price USD 2.08.Expected gross proceeds USD 8.5 million; warrant exercise could add about USD 15.1 million in gross proceeds.Closing targeted for June 3, 2026; H.C. Wainwright serving as exclusive placement agent.Proceeds earmarked for FDA approval work, related clinical studies, R&D, working capital; cash runway projected into Q1 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL59BJlC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","BJDX","SG9999014039.USD","NDAQ","LU2095319765.USD","SG9999014005.SGD","LU2210149790.SGD","BK4112","IE00BN0W2T93.GBP","BK4082","LU2210150020.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640423769","title":"Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2640423769","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640423769?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:19","pubTimestamp":1780417142,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUAC2YJ98:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640942593","title":"Press Release: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2640942593","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640942593?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:19","pubTimestamp":1780417140,"startTime":"0","endTime":"0","summary":"$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds upon the exercise in full of warrants. Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash, it is anticipated that the cash runway would extend well beyond FDA approval and first full year of commercialization. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The securities described above are being offered in a private placement under Section 4 of the Securities Act of 1933, as amended , and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640945425","title":"Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2640945425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640945425?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:13","pubTimestamp":1780405996,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics stock was up after the company announced a new strategic partnership.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-penny-stock-bluejay-diagnostics-bjdx-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-penny-stock-bluejay-diagnostics-bjdx-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917300","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917300","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917300?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:08","pubTimestamp":1780398493,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics  shares were up 179% in Tuesday premarket activity after the company announced a partnership with Argonaut Manufacturing Services to support the development of its Symphony platform.Decent  stock was 110% higher after the company's chairman disclosed acquiring the company's class B shares.VisionSys AI  shares were up 81%, adding to a 10% gain in the previous session.Picard Medical  stock was 59% higher after adding 14% in the Monday session.Cheetah Net Supply Chain Service  shares were up 23%, adding to a 9% gain in the previous session.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4159","BK4082","VSA","BK4204","LU0426412945.USD","LU1043141123.HKD","BJDX","CTNT","LU0545562505.USD","LU0994945656.USD","BK4120","LU0426417589.USD","DXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914715","title":"Bluejay Diagnostics partners with Argonaut Manufacturing Services to advance Symphony platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914715","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640914715?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:30","pubTimestamp":1780396230,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics formed a strategic partnership with Argonaut Manufacturing Services to advance its Symphony platform.Collaboration targets scalable U.S.-based manufacturing to support clinical development, future commercialization.Plan includes U.S. distribution support to widen domestic reach, strengthen supply-chain resilience, reduce tariff exposure.Partnership aims to cut reliance on overseas manufacturing, improve operational control, support business continuity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL2Ch2fs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014005.SGD","BK4082","SG9999014039.USD","LU2210149790.SGD","BJDX","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","NDAQ","LU2210150020.SGD","BK4112","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU2095319765.USD","SG9999014013.SGD","BK4588","BK4585","IE00BKPKM429.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914206","title":"Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914206","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640914206?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:30","pubTimestamp":1780396200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUA9NMZ2M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636001428","title":"Bluejay Diagnostics director Svetlana Dey acquires $25,000 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2636001428","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636001428?lang=en_us&edition=fundamental","pubTime":"2026-05-19 05:19","pubTimestamp":1779139168,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics director Svetlana Dey bought 12,500 common shares in a private placement priced at USD 2 per share.Direct holdings rose to 12,501 shares following the purchase.She also reported indirect beneficial ownership of 127 common shares held through Lana Management & Business Research International, LLC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL9gYdJ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bluejay Diagnostics director Svetlana Dey acquires $25,000 common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633417101","title":"Bluejay Diagnostics Q1 EPS $(1.95) Up From $(13.48) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2633417101","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633417101?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:25","pubTimestamp":1778185559,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.95) per share. This is a 85.53 percent increase over losses of $(13.48) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52390965/bluejay-diagnostics-q1-eps-1-95-up-from-13-48-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Bluejay Diagnostics Q1 EPS $(1.95) Up From $(13.48) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633017651","title":"Bluejay Diagnostics Q1 FY26 net loss unchanged at $1.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633017651","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633017651?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:04","pubTimestamp":1778184268,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics posted a net loss of about $1.9 million in Q1 2026, roughly flat versus Q1 2025.Cash and cash equivalents totaled about $3.7 million as of March 31, 2026.SYMON-II pivotal study enrollment reached about 680 patients as of May 5 toward a 750-patient target.Cartridge manufacturing readiness work with Sanyoseiko resolved technical process issues; company continued pursuing an FDA-focused path toward a future Symphony IL-6 510 submission after analytical and clinical validation.CEO Neil Dey cited “meaningful operational progress,” pointing to study enrollment momentum and manufacturing readiness aimed at moving Symphony toward regulatory readiness and future commercialization.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL2jYqGk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD","SG9999014005.SGD","BK4082","BK4112","LU2210150020.SGD","BK4585","BK4588","BJDX","IE00BN0W2V16.EUR","SG9999014021.USD","NDAQ","IE00B64PRP62.GBP","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633175201","title":"Bluejay Diagnostics Q1 Net Income USD -1.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633175201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633175201?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:01","pubTimestamp":1778184064,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX62DF29:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633317668","title":"Bluejay Diagnostics Provides First Quarter 2026 Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633317668","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633317668?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:01","pubTimestamp":1778184060,"startTime":"0","endTime":"0","summary":"ACTON, Mass., May  07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes in critical care settings, t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290498/0/en/Bluejay-Diagnostics-Provides-First-Quarter-2026-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629775126","title":"Bluejay Diagnostics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629775126","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629775126?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:07","pubTimestamp":1776715624,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics schedules annual shareholder meeting in Acton, Massachusetts in June 2026.Shareholders will vote on election of five directors for terms running to 2027 annual meeting.Ballot includes proposal to amend charter to allow reverse stock split, with board able to set ratio from 1-for-2 to 1-for-20.Investors will also vote on expanding 2021 Stock Plan share pool to 1,960,000 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDLc8HlsJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://bluejaydx.com","stockEarnings":[{"period":"1week","weight":-0.343},{"period":"1month","weight":0.4987},{"period":"3month","weight":0.4949},{"period":"6month","weight":0.0464},{"period":"1year","weight":-0.5304},{"period":"ytd","weight":0.0979}],"compareEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":-0.0286},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.056},{"period":"1year","weight":0.1914},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.09176},{"month":2,"riseRate":0.4,"avgChangeRate":-0.020494},{"month":3,"riseRate":0.4,"avgChangeRate":-0.104322},{"month":4,"riseRate":0.2,"avgChangeRate":-0.223757},{"month":5,"riseRate":0.4,"avgChangeRate":-0.039698},{"month":6,"riseRate":0.6,"avgChangeRate":-0.05619},{"month":7,"riseRate":0.5,"avgChangeRate":-0.039437},{"month":8,"riseRate":0,"avgChangeRate":-0.219139},{"month":9,"riseRate":0.25,"avgChangeRate":-0.176769},{"month":10,"riseRate":0.5,"avgChangeRate":-0.040237},{"month":11,"riseRate":0,"avgChangeRate":-0.194266},{"month":12,"riseRate":0.2,"avgChangeRate":-0.253394}],"exchange":"NASDAQ","name":"Bluejay Diagnostics Inc","nameEN":"Bluejay Diagnostics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bluejay Diagnostics Inc,BJDX,Bluejay Diagnostics Inc股票,Bluejay Diagnostics Inc股票老虎,Bluejay Diagnostics Inc股票老虎国际,Bluejay Diagnostics Inc行情,Bluejay Diagnostics Inc股票行情,Bluejay Diagnostics Inc股价,Bluejay Diagnostics Inc股市,Bluejay Diagnostics Inc股票价格,Bluejay Diagnostics Inc股票交易,Bluejay Diagnostics Inc股票购买,Bluejay Diagnostics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction